These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23628619)

  • 1. Serum fibroblast growth factor 19 levels are decreased in Chinese subjects with impaired fasting glucose and inversely associated with fasting plasma glucose levels.
    Fang Q; Li H; Song Q; Yang W; Hou X; Ma X; Lu J; Xu A; Jia W
    Diabetes Care; 2013 Sep; 36(9):2810-4. PubMed ID: 23628619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose.
    Zhang J; Li H; Zhou H; Fang L; Xu J; Yan H; Chen S; Song Q; Zhang Y; Xu A; Fang Q; Ye Y; Jia W
    Sci Rep; 2017 Jul; 7(1):6042. PubMed ID: 28729691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease of FGF19 contributes to the increase of fasting glucose in human in an insulin-independent manner.
    Zhang J; Li H; Bai N; Xu Y; Song Q; Zhang L; Wu G; Chen S; Hou X; Wang C; Wei L; Xu A; Fang Q; Jia W
    J Endocrinol Invest; 2019 Sep; 42(9):1019-1027. PubMed ID: 30852757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum fibroblast growth factor 19 levels with visceral fat accumulation is independent of glucose tolerance status.
    Hu X; Xiong Q; Xu Y; Zhang X; Pan X; Ma X; Bao Y; Jia W
    Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):119-125. PubMed ID: 29174027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.
    Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Hansis-Diarte A; Jenkinson C; Tripathy D; Folli F
    Acta Diabetol; 2018 Feb; 55(2):139-148. PubMed ID: 29151224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study.
    Li Y; Feng D; Esangbedo IC; Zhao Y; Han L; Zhu Y; Fu J; Li G; Wang D; Wang Y; Li M; Gao S; Willi SM
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Levels of Meteorin-Like (Metrnl) Are Increased in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Are Associated with Insulin Resistance.
    Wang K; Li F; Wang C; Deng Y; Cao Z; Cui Y; Xu K; Ln P; Sun Y
    Med Sci Monit; 2019 Mar; 25():2337-2343. PubMed ID: 30928991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia.
    Basu R; Barosa C; Jones J; Dube S; Carter R; Basu A; Rizza RA
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E409-17. PubMed ID: 23345093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.
    Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K
    Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
    Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
    Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
    Chakarova N; Tankova T; Atanassova I; Dakovska L
    Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of type 2 diabetes mellitus according to 2-h plasma glucose level: The Korean Genome and Epidemiology Study (KoGES).
    Park SK; Ryoo JH; Oh CM; Choi JM; Choi YJ; Lee KO; Jung JY
    Diabetes Res Clin Pract; 2018 Dec; 146():130-137. PubMed ID: 28951335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between GDF15 levels and pre-diabetes in non-obese subjects.
    Hung HC; Wu HT; Lin CH; Chou HW; Ou HY; Chang CJ
    J Investig Med; 2022 Jan; 70(1):79-84. PubMed ID: 34376526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of insulin resistance and β cell function in the development of newly diagnosed type 2 diabetes].
    Chen X; Su M; Wang C; Wu Z; Li S; Ying X; Wei G; Fu C; Jiang Q
    Wei Sheng Yan Jiu; 2015 Nov; 44(6):881-6. PubMed ID: 26738376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.
    Chavez AO; Molina-Carrion M; Abdul-Ghani MA; Folli F; Defronzo RA; Tripathy D
    Diabetes Care; 2009 Aug; 32(8):1542-6. PubMed ID: 19487637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.
    Li H; Bao Y; Xu A; Pan X; Lu J; Wu H; Lu H; Xiang K; Jia W
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2151-6. PubMed ID: 19318452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
    Madhu SV; Muduli SK; Avasthi R
    Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.